Page last updated: 2024-08-24

dexamethasone 17-valerate and bufexamac

dexamethasone 17-valerate has been researched along with bufexamac in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kimata, H	1

Trials

1 trial(s) available for dexamethasone 17-valerate and bufexamac

Article	Year
Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1999, Volume: 82, Issue:3 Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Allergic Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Arylsulfonates; Bufexamac; Dermatitis, Atopic; Dexamethasone; Female; Histamine Antagonists; Humans; Immunoglobulin E; Immunoglobulin G; Interleukins; Lymphokines; Male; Substance Withdrawal Syndrome; Sulfonium Compounds; Th2 Cells; Treatment Outcome	1999

Article

Year

Selective enhancement of production of IgE, IgG4, and Th2-cell cytokine during the rebound phenomenon in atopic dermatitis and prevention by suplatast tosilate.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1999, Volume: 82, Issue:3

Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Anti-Allergic Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibody Formation; Arylsulfonates; Bufexamac; Dermatitis, Atopic; Dexamethasone; Female; Histamine Antagonists; Humans; Immunoglobulin E; Immunoglobulin G; Interleukins; Lymphokines; Male; Substance Withdrawal Syndrome; Sulfonium Compounds; Th2 Cells; Treatment Outcome

1999